IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (IRWD)

Q: What does CUSIP 46333X108 represent in this 13F holders report?

CUSIP 46333X108 is the security identifier for IRWD - IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value used to aggregate holder disclosures.

Q: How many institutions held IRWD - IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value in Q3 2014?

138 institutional investors reported IRWD - IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value for Q3 2014. Use the holders table for investor-level position and value details.

CUSIP: 46333X108

Q3 2014 13F Holders as of 30 Sep 2014

Type / Class: Equity / Class A common stock, $0.001 par value
Shares outstanding: 162,690,355
Total 13F shares: 131,914,423
Share change: +5,663,803
Total reported value: $1,709,440,539
Put/Call ratio: 295%
Price per share: $12.96
Number of holders: 138
Value change: +$65,713,386
Number of buys: 64
Number of sells: 51

Quarterly Holders Quick Answers

What is CUSIP 46333X108?
CUSIP 46333X108 identifies IRWD - IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2014
Previous quarter: Q2 2014

Recent filing periods for CUSIP 46333X108:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Institutional Holders of IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (IRWD) as of Q3 2014

As of 30 Sep 2014, IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (IRWD) was held by 138 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 131,914,423 shares. The largest 10 holders included FMR LLC, WELLINGTON MANAGEMENT CO LLP, JANUS CAPITAL MANAGEMENT LLC, ORBIMED ADVISORS LLC, MORGAN STANLEY, VANGUARD GROUP INC, BVF INC/IL, DEUTSCHE BANK AG\, STATE OF WISCONSIN INVESTMENT BOARD, and BlackRock Fund Advisors. This page lists 138 institutional shareholders reporting positions in this security for the Q3 2014 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.